ABCD3 and myeloid sarcoma: Gray and coworkers further supported their hypothesis by showing decreased expression of ABCD3 mRNA together with a reduction of ABCD3/PMP70 immunoreactivity in gray matter within and outside of lesions, as well as a slight elevation of VLCFA levels in post mortem cortical gray matter from MS patients [314].